Adrenal Cortical Carcinoma
📧 Sign up to get email alerts when something new happens for Adrenal Cortical Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors [Phase 2]
This Phase 2 trial update describes testing nivolumab plus ipilimumab in patients with a broad set of rare tumors and notes the study status…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer [Phase 2]
A Phase 2 clinical trial evaluating cabozantinib in combination with pembrolizumab for locally advanced, metastatic, or unresectable adrenal…
-
CLINICAL_TRIALS trial_result · 2022-11-28Clinical Trial Update: Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors [Phase 2]
A Phase 2 clinical trial evaluating cabozantinib-s-maleate in pediatric patients with recurrent, refractory, or newly diagnosed sarcomas, Wi…
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor [Phase 3]
Phase 3 trial evaluating cisplatin-based chemotherapy and/or surgery for young patients with adrenal cortical carcinoma completed with resul…
-
CLINICAL_TRIALS trial_result · 2015-12-28Clinical Trial Update: Spectroscopy With Surface Coils and Decoupling [Phase 1]
A Phase 1 clinical trial evaluating spectroscopy with surface coils and decoupling has completed, across multiple cancer indications. Sponso…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.